Optimising science
Posts tagged “1degreebio”
-
Funding news, new epigenetic portal from 1DegreeBio
It's been a big month in the news department for 1DegreeBio, a portfolio company of ours that aids researchers in sourcing and reviewing antibodies. The Toronto-based start-up announced yesterday that it had closed its Series B round of funding, led by a follow-on investment by Digital Science. Philip Armstrong, CEO of Jovian Capital Corporation and 1DegreeBio senior management also participated in the round.
-
New market report shows antibody usage growing, efficacy still an issue
Our colleagues at 1DegreeBio today released their 2012 Antibody Sourcing and Usage Report, a comprehensive report surveying 400 life scientists on their antibody purchasing habits and practices.
The report showed signs of growth in usage levels,...
